Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy

Kazumasa Unno, Rei Shibata, Hideo Izawa, Akihiro Hirashiki, Yosuke Murase, Takashi Yamada, Masakazu Kobayashi, Akiko Noda, Kohzo Nagata, Noriyuki Ouchi, Toyoaki Murohara

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Adiponectin is an adipose-derived plasma protein that exhibits beneficial actions on the heart. Recently, it was shown that adiponectin levels were elevated in patients with systolic heart failure. Objective: To investigate the association between adiponectin levels and left ventricular (LV) diastolic function in patients with hypertrophic cardiomyopathy (HCM), characterised by diastolic dysfunction. Methods: Twenty-six patients with HCM showing LV ejection fraction of >60% were enrolled. LV pressure half-time (T1/2) was measured as an index of myocardial relaxation. Patients were divided into two groups on the basis of baseline T1/2 (group A: T1/2< 35 ms, group B: T1/2≥ 35 ms). Blood samples were simultaneously collected from the coronary sinus (CS) and aortic root (Ao) as well as the peripheral vein (PV) for measurement of plasma adiponectin levels. Results: Plasma adiponectin levels were significantly higher in group B than in group A. Adiponectin levels in the PV were positively correlated with the baseline T 1/2 in patients with HCM. The transcardiac gradient of adiponectin as calculated by the Ao-CS difference was significantly higher in group A than in group B. The transcardiac gradient of adiponectin also inversely correlated with the baseline T1/2 and adiponectin levels in PV in patients with HCM. The expression of AdipoR1 but not AdipoR2 in the heart decreased in group B. The baseline T1/2 was negatively associated with AdipoR1 expression in patients with HCM. Conclusions: These data document that adiponectin is an indicator of LV diastolic dysfunction in patients with HCM.

Original languageEnglish
Pages (from-to)357-361
Number of pages5
JournalHeart
Volume96
Issue number5
DOIs
Publication statusPublished - 01-03-2010
Externally publishedYes

Fingerprint

Hypertrophic Cardiomyopathy
Adiponectin
Left Ventricular Dysfunction
Veins
Coronary Sinus
Systolic Heart Failure
Ventricular Pressure
Left Ventricular Function
Stroke Volume
Blood Proteins

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Unno, Kazumasa ; Shibata, Rei ; Izawa, Hideo ; Hirashiki, Akihiro ; Murase, Yosuke ; Yamada, Takashi ; Kobayashi, Masakazu ; Noda, Akiko ; Nagata, Kohzo ; Ouchi, Noriyuki ; Murohara, Toyoaki. / Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. In: Heart. 2010 ; Vol. 96, No. 5. pp. 357-361.
@article{3b8be3eaf68146f8bc42546c8c3ede64,
title = "Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy",
abstract = "Background: Adiponectin is an adipose-derived plasma protein that exhibits beneficial actions on the heart. Recently, it was shown that adiponectin levels were elevated in patients with systolic heart failure. Objective: To investigate the association between adiponectin levels and left ventricular (LV) diastolic function in patients with hypertrophic cardiomyopathy (HCM), characterised by diastolic dysfunction. Methods: Twenty-six patients with HCM showing LV ejection fraction of >60{\%} were enrolled. LV pressure half-time (T1/2) was measured as an index of myocardial relaxation. Patients were divided into two groups on the basis of baseline T1/2 (group A: T1/2< 35 ms, group B: T1/2≥ 35 ms). Blood samples were simultaneously collected from the coronary sinus (CS) and aortic root (Ao) as well as the peripheral vein (PV) for measurement of plasma adiponectin levels. Results: Plasma adiponectin levels were significantly higher in group B than in group A. Adiponectin levels in the PV were positively correlated with the baseline T 1/2 in patients with HCM. The transcardiac gradient of adiponectin as calculated by the Ao-CS difference was significantly higher in group A than in group B. The transcardiac gradient of adiponectin also inversely correlated with the baseline T1/2 and adiponectin levels in PV in patients with HCM. The expression of AdipoR1 but not AdipoR2 in the heart decreased in group B. The baseline T1/2 was negatively associated with AdipoR1 expression in patients with HCM. Conclusions: These data document that adiponectin is an indicator of LV diastolic dysfunction in patients with HCM.",
author = "Kazumasa Unno and Rei Shibata and Hideo Izawa and Akihiro Hirashiki and Yosuke Murase and Takashi Yamada and Masakazu Kobayashi and Akiko Noda and Kohzo Nagata and Noriyuki Ouchi and Toyoaki Murohara",
year = "2010",
month = "3",
day = "1",
doi = "10.1136/hrt.2009.172320",
language = "English",
volume = "96",
pages = "357--361",
journal = "Heart",
issn = "1355-6037",
publisher = "BMJ Publishing Group",
number = "5",

}

Unno, K, Shibata, R, Izawa, H, Hirashiki, A, Murase, Y, Yamada, T, Kobayashi, M, Noda, A, Nagata, K, Ouchi, N & Murohara, T 2010, 'Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy', Heart, vol. 96, no. 5, pp. 357-361. https://doi.org/10.1136/hrt.2009.172320

Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. / Unno, Kazumasa; Shibata, Rei; Izawa, Hideo; Hirashiki, Akihiro; Murase, Yosuke; Yamada, Takashi; Kobayashi, Masakazu; Noda, Akiko; Nagata, Kohzo; Ouchi, Noriyuki; Murohara, Toyoaki.

In: Heart, Vol. 96, No. 5, 01.03.2010, p. 357-361.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy

AU - Unno, Kazumasa

AU - Shibata, Rei

AU - Izawa, Hideo

AU - Hirashiki, Akihiro

AU - Murase, Yosuke

AU - Yamada, Takashi

AU - Kobayashi, Masakazu

AU - Noda, Akiko

AU - Nagata, Kohzo

AU - Ouchi, Noriyuki

AU - Murohara, Toyoaki

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Background: Adiponectin is an adipose-derived plasma protein that exhibits beneficial actions on the heart. Recently, it was shown that adiponectin levels were elevated in patients with systolic heart failure. Objective: To investigate the association between adiponectin levels and left ventricular (LV) diastolic function in patients with hypertrophic cardiomyopathy (HCM), characterised by diastolic dysfunction. Methods: Twenty-six patients with HCM showing LV ejection fraction of >60% were enrolled. LV pressure half-time (T1/2) was measured as an index of myocardial relaxation. Patients were divided into two groups on the basis of baseline T1/2 (group A: T1/2< 35 ms, group B: T1/2≥ 35 ms). Blood samples were simultaneously collected from the coronary sinus (CS) and aortic root (Ao) as well as the peripheral vein (PV) for measurement of plasma adiponectin levels. Results: Plasma adiponectin levels were significantly higher in group B than in group A. Adiponectin levels in the PV were positively correlated with the baseline T 1/2 in patients with HCM. The transcardiac gradient of adiponectin as calculated by the Ao-CS difference was significantly higher in group A than in group B. The transcardiac gradient of adiponectin also inversely correlated with the baseline T1/2 and adiponectin levels in PV in patients with HCM. The expression of AdipoR1 but not AdipoR2 in the heart decreased in group B. The baseline T1/2 was negatively associated with AdipoR1 expression in patients with HCM. Conclusions: These data document that adiponectin is an indicator of LV diastolic dysfunction in patients with HCM.

AB - Background: Adiponectin is an adipose-derived plasma protein that exhibits beneficial actions on the heart. Recently, it was shown that adiponectin levels were elevated in patients with systolic heart failure. Objective: To investigate the association between adiponectin levels and left ventricular (LV) diastolic function in patients with hypertrophic cardiomyopathy (HCM), characterised by diastolic dysfunction. Methods: Twenty-six patients with HCM showing LV ejection fraction of >60% were enrolled. LV pressure half-time (T1/2) was measured as an index of myocardial relaxation. Patients were divided into two groups on the basis of baseline T1/2 (group A: T1/2< 35 ms, group B: T1/2≥ 35 ms). Blood samples were simultaneously collected from the coronary sinus (CS) and aortic root (Ao) as well as the peripheral vein (PV) for measurement of plasma adiponectin levels. Results: Plasma adiponectin levels were significantly higher in group B than in group A. Adiponectin levels in the PV were positively correlated with the baseline T 1/2 in patients with HCM. The transcardiac gradient of adiponectin as calculated by the Ao-CS difference was significantly higher in group A than in group B. The transcardiac gradient of adiponectin also inversely correlated with the baseline T1/2 and adiponectin levels in PV in patients with HCM. The expression of AdipoR1 but not AdipoR2 in the heart decreased in group B. The baseline T1/2 was negatively associated with AdipoR1 expression in patients with HCM. Conclusions: These data document that adiponectin is an indicator of LV diastolic dysfunction in patients with HCM.

UR - http://www.scopus.com/inward/record.url?scp=77649226769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649226769&partnerID=8YFLogxK

U2 - 10.1136/hrt.2009.172320

DO - 10.1136/hrt.2009.172320

M3 - Article

VL - 96

SP - 357

EP - 361

JO - Heart

JF - Heart

SN - 1355-6037

IS - 5

ER -